These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 1902321)

  • 21. The chronic fatigue syndrome: definition, current studies and lessons for fibromyalgia research.
    Komaroff AL; Goldenberg D
    J Rheumatol Suppl; 1989 Nov; 19():23-7. PubMed ID: 2691680
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ERK1/2, MEK1/2 and p38 downstream signalling molecules impaired in CD56 dim CD16+ and CD56 bright CD16 dim/- natural killer cells in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis patients.
    Huth TK; Staines D; Marshall-Gradisnik S
    J Transl Med; 2016 Apr; 14():97. PubMed ID: 27098723
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibodies to Epstein-Barr virus in patients with chronic fatigue.
    Matthews DA; Lane TJ; Manu P
    South Med J; 1991 Jul; 84(7):832-40. PubMed ID: 1648795
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Serum BAFF and APRIL Levels, T-Lymphocyte Subsets, and Immunoglobulins after B-Cell Depletion Using the Monoclonal Anti-CD20 Antibody Rituximab in Myalgic Encephalopathy/Chronic Fatigue Syndrome.
    Lunde S; Kristoffersen EK; Sapkota D; Risa K; Dahl O; Bruland O; Mella O; Fluge Ø
    PLoS One; 2016; 11(8):e0161226. PubMed ID: 27536947
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Characterisation of cell functions and receptors in Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME).
    Hardcastle SL; Brenu EW; Johnston S; Nguyen T; Huth T; Wong N; Ramos S; Staines D; Marshall-Gradisnik S
    BMC Immunol; 2015 Jun; 16():35. PubMed ID: 26032326
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The effects of a laboratory stressor on natural killer cell function in chronic fatigue syndrome patients.
    Wemm KM; Trestman RL
    Psychosomatics; 1991; 32(4):470-1. PubMed ID: 1961870
    [No Abstract]   [Full Text] [Related]  

  • 27. Search for an association between Epstein-Barr virus infection and the chronic fatigue syndrome.
    Joncas JH
    Can Dis Wkly Rep; 1991 Jan; 17 Suppl 1E():43-7. PubMed ID: 1669352
    [No Abstract]   [Full Text] [Related]  

  • 28. Natural killer cells and natural killer cell activity in chronic fatigue syndrome.
    Whiteside TL; Friberg D
    Am J Med; 1998 Sep; 105(3A):27S-34S. PubMed ID: 9790479
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenic tracks in fatigue syndromes.
    Moutschen M; Triffaux JM; Demonty J; Legros JJ; Lefèbvre PJ
    Acta Clin Belg; 1994; 49(6):274-89. PubMed ID: 7871934
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Chronic Epstein-Barr virus infection.
    Pallavicini EB; Brambilla G; Porta C; Cannatelli G; Battistini E; Gorini M
    Haematologica; 1992; 77(4):359-60. PubMed ID: 1330851
    [No Abstract]   [Full Text] [Related]  

  • 31. Psychoneuroimmunology and Natural Killer Cells: The Chromium-Release Whole-Blood Assay.
    Fletcher MA; Barnes Z; Broderick G; Klimas NG
    Methods Mol Biol; 2018; 1781():209-220. PubMed ID: 29705850
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decreased expression of CD69 in chronic fatigue syndrome in relation to inflammatory markers: evidence for a severe disorder in the early activation of T lymphocytes and natural killer cells.
    Mihaylova I; DeRuyter M; Rummens JL; Bosmans E; Maes M
    Neuro Endocrinol Lett; 2007 Aug; 28(4):477-83. PubMed ID: 17693977
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Immunopathogenesis of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS)].
    Yamamura T; Ono H; Sato W
    Brain Nerve; 2018 Jan; 70(1):35-40. PubMed ID: 29348373
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The chronic fatigue syndrome. A multifactorial approach and the treatment possibilities].
    Pinardi G; Scarlato G
    Recenti Prog Med; 1990 Dec; 81(12):773-7. PubMed ID: 2075278
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Behavior of lymphocyte subpopulations in acute lymphoblastic leukemia in children].
    Sciotto A; Minniti C; Bottaro G; Castello R; Russo A
    Minerva Pediatr; 1984 May; 36(10):519-24. PubMed ID: 6332974
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME.
    Scheibenbogen C; Loebel M; Freitag H; Krueger A; Bauer S; Antelmann M; Doehner W; Scherbakov N; Heidecke H; Reinke P; Volk HD; Grabowski P
    PLoS One; 2018; 13(3):e0193672. PubMed ID: 29543914
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunological aspects of pathophysiology of chronic fatigue syndrome].
    Matsumoto Y
    Nihon Rinsho Meneki Gakkai Kaishi; 1999 Jun; 22(3):111-22. PubMed ID: 11126662
    [No Abstract]   [Full Text] [Related]  

  • 38. Role of adaptive and innate immune cells in chronic fatigue syndrome/myalgic encephalomyelitis.
    Brenu EW; Huth TK; Hardcastle SL; Fuller K; Kaur M; Johnston S; Ramos SB; Staines DR; Marshall-Gradisnik SM
    Int Immunol; 2014 Apr; 26(4):233-42. PubMed ID: 24343819
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune responsiveness in chronic fatigue syndrome.
    Milton JD; Clements GB; Edwards RH
    Postgrad Med J; 1991 Jun; 67(788):532-7. PubMed ID: 1656416
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Chronic fatigue syndrome--cases in the Kanebo Memorial Hospital].
    Ogawa R; Toyama S; Matsumoto H
    Nihon Rinsho; 1992 Nov; 50(11):2648-52. PubMed ID: 1337561
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.